Literature DB >> 20043630

Unique diastereoselectivity trends in aminyl radical cyclizations onto silyl enol ethers.

Maria Zlotorzynska1, Huimin Zhai, Glenn M Sammis.   

Abstract

The cyclization of nitrogen-centered radicals onto silyl enol ethers is an efficient method for the synthesis of polyhydroxylated alkaloids as the 2-hydroxymethylpyrrolidine core can be readily accessed from a linear precursor. During our studies on the synthesis of polyhydroxylated alkaloid CYB-3, we found that the diastereoselectivity of the cyclization was dependent on a complex combination of sterics and olefin geometry. A more thorough understanding of the factors that lead to high diastereoselectivites would greatly expand the utility of this methodology in complex natural product synthesis. We have found that cyclization diastereoselectivities of substrates with alkyl or aryl substitution were excellent regardless of olefin geometry or substitution pattern. When electronegative substituents were introduced adjacent to the silyl enol ether, only Z-silyl enol ethers provide high diastereoselectivites. Temperature, steric size of the silyl group, and sterics and electronics of the metal hydride affected the selectivity to a lesser extent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20043630     DOI: 10.1021/jo902426z

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Toward the ABCD Core of the Calyciphylline A-Type Daphniphyllum Alkaloids: Solvent non-Innocence in Neutral Aminyl Radical Cyclizations.

Authors:  Jennifer L Stockdill; Alberto M Lopez; Ahmad A Ibrahim
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

2.  Rapid access to the heterocyclic core of the calyciphylline A and daphnicyclidin A-type Daphniphyllum alkaloids via tandem cyclization of a neutral aminyl radical.

Authors:  Ahmad A Ibrahim; Alexander N Golonka; Alberto M Lopez; Jennifer L Stockdill
Journal:  Org Lett       Date:  2014-02-07       Impact factor: 6.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.